Literature DB >> 9144191

Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor.

U Rodeck1, M Jost, J DuHadaway, C Kari, P J Jensen, B Risse, D L Ewert.   

Abstract

Cell-substratum adhesion is an essential requirement for survival of human neonatal keratinocytes in vitro. Similarly, activation of the epidermal growth factor receptor (EGF-R) has recently been implicated not only in cell cycle progression but also in survival of normal keratinocytes. The mechanisms by which either cell-substratum adhesion or EGF-R activation protect keratinocytes from programmed cell death are poorly understood. Here we describe that blockade of the EGF-R and inhibition of substratum adhesion share a common downstream event, the down-regulation of the cell death protector Bcl-xL. Expression of Bcl-xL protein was down-regulated during forced suspension culture of keratinocytes, concurrent with large-scale apoptosis. Similarly, EGF-R blockade was accompanied by down-regulation of Bcl-xL steady-state mRNA and protein levels to an extent comparable to that observed in forced suspension culture. However, down-regulation of Bcl-xL expression by EGF-R blockade was not accompanied by apoptosis; in this case, a second signal, generated by passaging, was required to induce rapid and large-scale apoptosis. These findings are consistent with the conclusions that (i) Bcl-xL represents a shared molecular target for signaling through cell-substrate adhesion receptors and the EGF-R, and (ii) reduced levels of Bcl-xL expression through EGF-R blockade lower the tolerance of keratinocytes for cell death signals generated by cellular stress.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144191      PMCID: PMC24632          DOI: 10.1073/pnas.94.10.5067

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K.

Authors:  S N Farrow; J H White; I Martinou; T Raven; K T Pun; C J Grinham; J C Martinou; R Brown
Journal:  Nature       Date:  1995-04-20       Impact factor: 49.962

2.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.

Authors:  R Yao; G M Cooper
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

3.  Heterodimerization with Bax is required for Bcl-2 to repress cell death.

Authors:  X M Yin; Z N Oltvai; S J Korsmeyer
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

Review 4.  Checkpoints of dueling dimers foil death wishes.

Authors:  Z N Oltvai; S J Korsmeyer
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

5.  Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1.

Authors:  D A Vardy; C Kari; G S Lazarus; P J Jensen; A Zilberstein; G D Plowman; U Rodeck
Journal:  J Cell Physiol       Date:  1995-05       Impact factor: 6.384

6.  Induction of apoptosis by the Bcl-2 homologue Bak.

Authors:  T Chittenden; E A Harrington; R O'Connor; C Flemington; R J Lutz; G I Evan; B C Guild
Journal:  Nature       Date:  1995-04-20       Impact factor: 49.962

7.  Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak.

Authors:  M C Kiefer; M J Brauer; V C Powers; J J Wu; S R Umansky; L D Tomei; P J Barr
Journal:  Nature       Date:  1995-04-20       Impact factor: 49.962

8.  Expression of the wt1 Wilms' tumor gene by normal and malignant human melanocytes.

Authors:  U Rodeck; A Bossler; C Kari; C W Humphreys; T Györfi; J Maurer; E Thiel; H D Menssen
Journal:  Int J Cancer       Date:  1994-10-01       Impact factor: 7.396

9.  Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.

Authors:  C Sell; R Baserga; R Rubin
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

10.  Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix.

Authors:  N Boudreau; C J Sympson; Z Werb; M J Bissell
Journal:  Science       Date:  1995-02-10       Impact factor: 47.728

View more
  8 in total

1.  Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

Authors:  J S Damiano; A E Cress; L A Hazlehurst; A A Shtil; W S Dalton
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

2.  Analysis of the transcriptional program induced by Raf in epithelial cells.

Authors:  A Schulze; K Lehmann; H B Jefferies; M McMahon; J Downward
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

3.  Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway.

Authors:  M Jost; T M Huggett; C Kari; U Rodeck
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

4.  Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro.

Authors:  F Podestà; G Romeo; W H Liu; S Krajewski; J C Reed; C Gerhardinger; M Lorenzi
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  EEDA: a protein associated with an early stage of stratified epithelial differentiation.

Authors:  Lijie Sun; David G Ryan; Mingyuan Zhou; Tung-Tien Sun; Robert M Lavker
Journal:  J Cell Physiol       Date:  2006-01       Impact factor: 6.384

Review 6.  The hair follicle: dying for attention.

Authors:  G Cotsarelis
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

7.  Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor.

Authors:  Xiaodong Shen; Randall H Kramer
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

8.  Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.

Authors:  Yuan Liu; Philip W Smith; David R Jones
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.